XM does not provide services to residents of the United States of America.

New Zealand escalates dairy trade dispute with Canada



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>New Zealand escalates dairy trade dispute with Canada</title></head><body>

WELLINGTON, Oct 18 (Reuters) -The New Zealand government said on Friday it had escalated its long-running trade dispute with Canada over access for its dairy products into the North American country.

New Zealand Trade Minister Todd McClay said his government had notified the Canadian government and other members of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) trade agreement that it had triggered mandatory negotiations in the dairy dispute with Canada.

These now must begin within 15 days.

New Zealand launched a claim against Canada in May 2022, arguing that Ottawa's implementation of dairy tariff rate quotas under the trade pact were against the agreement's rules.

In particular, New Zealand claims that although Canada agreed to allow some dairy market access to foreign firms through a system of tariff-rate quotas, it was in fact improperly allocating some of them to domestic firms.

"As a matter of principle, the New Zealand Government expects our trade partners to treat our exporters fairly and within the rules of our agreements," McClay said in a statement.

"Canada is not doing that in respect to the dairy quotas that were negotiated and agreed with New Zealand," he said.

Five other CPTPP members including Australia, Japan, Mexico, Peru and Singapore have joined New Zealand in the dispute, and in September 2023 both New Zealand and Canada claimed a panel of arbitrators found in their favour.

Canada's High Commission in Wellington did not immediately respond to a request for comment.

New Zealand said on Friday that Canada had not complied with the findings within a reasonable amount of time.

This is the first dispute New Zealand has taken under a free trade agreement, and the first dispute that has been taken by any party under CPTPP, the New Zealand government said.



Reporting by Lucy Craymer; Editing by Jamie Freed

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.